Orthofix Medical (OFIX) Finished Goods (2011 - 2026)

Orthofix Medical (OFIX) has 16 years of Finished Goods data on file, last reported at $87.7 million in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods fell 4.21% year-over-year to $87.7 million; the trailing twelve-month figure through Mar 2026 stood at $87.7 million (down 4.21% YoY), and the FY2025 full-year result was $86.2 million, down 18.18% from the prior year.
• Finished Goods for Q1 2026 stood at $87.7 million, up from $86.2 million in the prior quarter.
• Across five years, Finished Goods topped out at $140.7 million in Q3 2023 and bottomed at $24.6 million in Q1 2022.
• A 5-year average of $97.6 million and a median of $91.6 million in 2025 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods surged 471.49% in 2023 and slumped 31.16% in 2025, its largest moves.
• Tracing OFIX's Finished Goods over 5 years: stood at $63.9 million in 2022, then soared by 119.6% to $140.3 million in 2023, then dropped by 24.89% to $105.4 million in 2024, then dropped by 18.18% to $86.2 million in 2025, then climbed by 1.79% to $87.7 million in 2026.
• According to Business Quant data, Finished Goods over the past three periods registered $87.7 million, $86.2 million, and $88.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison